Accessibility Menu
 
Rallybio logo

Rallybio

(NASDAQ) RLYB

Current Price$8.84
Market Cap$45.86M
Since IPO (2021)-92%
5 YearN/A
1 Year+78%
1 Month+71%

Rallybio Financials at a Glance

Market Cap

$45.86M

Revenue (TTM)

$858.00K

Net Income (TTM)

$8.98M

EPS (TTM)

$-1.68

P/E Ratio

-5.16

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$8.84

Volume

745

Open

$9.06

Previous Close

$8.67

Daily Range

$8.68 - $9.06

52-Week Range

$1.76 - $11.49

RLYB News

No articles available.

RLYB: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rallybio

Industry

Biotechnology

Employees

14

CEO

Stephen Uden, MD

Headquarters

New Haven, CT 06510, US

RLYB Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-39%

Net Income Margin

-10%

Return on Equity

-15%

Return on Capital

-57%

Return on Assets

-14%

Earnings Yield

-19.38%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$45.86M

Shares Outstanding

5.29M

Volume

745

Short Interest

0.00%

Avg. Volume

132.42K

Financials (TTM)

Gross Profit

$766.00K

Operating Income

$28.06M

EBITDA

$27.97M

Operating Cash Flow

$29.81M

Capital Expenditure

$0.00

Free Cash Flow

$29.81M

Cash & ST Invst.

$54.74M

Total Debt

$176.00K

Rallybio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$222.00K

+484.2%

Gross Profit

$219.00K

+2637.5%

Gross Margin

98.65%

N/A

Market Cap

$45.86M

N/A

Market Cap/Employee

$3.06M

N/A

Employees

15

N/A

Net Income

$5.85M

+47.0%

EBITDA

$6.41M

+44.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$54.56M

-16.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$82.00K

N/A

Short Term Debt

$94.00K

-39.0%

Return on Assets

-14.42%

N/A

Return on Invested Capital

-56.97%

N/A

Free Cash Flow

$4.68M

+52.6%

Operating Cash Flow

$4.68M

+52.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IBIOiBio, Inc.
$2.14+2.88%
XCURExicure, Inc.
$4.62+3.36%
BOLDBoundless Bio, Inc.
$1.14+0.44%
TAOXTAO Synergies Inc.
$6.55+3.39%

Trending Stocks

Symbol / CompanyPricePrice Chg
TERNTerns Pharmaceuticals
$52.76+0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.25-0.05%
UGROUrban-gro
$15.34+1.19%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.41+0.03%

Questions About RLYB

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.